U.S. Diversified Financial Stock News

Even though Resolute Holdings Management, Inc. ( NYSE:RHLD ) posted strong earnings, investors appeared to be...

Readers hoping to buy Concentra Group Holdings Parent, Inc. ( NYSE:CON ) for its dividend will need to make their move...

LandBridge Company LLC ( NYSE:LB ) just reported healthy earnings but the stock price didn't move much. We think that...

The subdued stock price reaction suggests that Loar Holdings Inc.'s ( NYSE:LOAR ) strong earnings didn't offer any...

PACS Group, Inc. ( NYSE:PACS ) investors will be delighted, with the company turning in some strong numbers with its...

Shareholders appeared unconcerned with Crane NXT, Co.'s ( NYSE:CXT ) lackluster earnings report last week. Our analysis...

As you might know, Septerna, Inc. ( NASDAQ:SEPN ) just kicked off its latest quarterly results with some very strong...

Traeger, Inc. ( NYSE:COOK ) shareholders are probably feeling a little disappointed, since its shares fell 2.7% to...

Merck stock performance snapshot and recent context Merck (MRK) trades around $113.45, with the stock roughly flat over the past week and down about 6% over the past month and 5% over the past 3 months. This sets the backdrop for a closer look at its fundamentals. See our latest analysis for Merck. While the 30 day share price return declined 5.6% and the 90 day share price return declined 4.9%, the year to date share price return of 6.6% and 1 year total shareholder return of 60.0% indicate...

The most recent earnings report from ESAB Corporation ( NYSE:ESAB ) was disappointing for shareholders. While the...

Perimeter Solutions, Inc. recently reported first-quarter 2026 results, with sales rising to US$125.07 million and net income reaching US$72.94 million, alongside higher earnings per share versus a year earlier. Management also highlighted an active mergers and acquisitions pipeline, emphasizing a repeatable “small but essential component” acquisition model that focuses on recurring revenue and operational improvement after deals close. We’ll now examine how Perimeter Solutions’ strong...

In early May 2026, Ormat Technologies, Inc. reported first-quarter revenue of US$403.91 million and net income of US$44.07 million, reaffirmed its 2026 revenue guidance of US$1.11–1.16 billion, recognized US$8.11 million in long-lived asset impairments, and declared a quarterly dividend of US$0.12 per share. An interesting aspect of this update is that Ormat combined record quarterly revenue and slightly higher earnings per share with fresh asset impairments, a recently completed US$1.00...

AI is not just a story about mega caps any more, and smaller companies at the cutting edge of machine learning, automation, and data intelligence are starting to attract serious interest. With inflation trends, energy costs, and interest rate expectations pulling markets in different directions, many investors are looking for focused ways to target potential long term growth rather than broad market exposure. The AI Small Caps screener is built for that; it highlights earlier stage stocks...

Atour Lifestyle Holdings (NasdaqGS:ATAT) is back in focus after reporting strong first quarter 2026 results, raising its full year revenue guidance, expanding its hotel network, and continuing cash returns through dividends and share repurchases. See our latest analysis for Atour Lifestyle Holdings. Despite the positive Q1 2026 earnings, raised 2026 revenue guidance and a fresh dividend announcement, Atour Lifestyle Holdings' share price has eased recently. The 7-day share price return is...

Some Cipher Digital Inc. ( NASDAQ:CIFR ) shareholders may be a little concerned to see that the Independent Director...

High inflation risks, sticky interest rates and energy driven cost pressures have pushed many investors toward income they can see and touch. That is where the Dividend Fortresses screener comes in, focusing on stocks with dividend yields above 5% that aim to offer both resilience and meaningful cash payouts. Instead of trying to guess the next macro twist, you can look at companies that already return a high share of cash to shareholders. In this article you will see three stocks from the...

Tradeweb Markets overview and recent share performance Tradeweb Markets (TW) operates electronic marketplaces across fixed income, equities, and money markets. Its stock has recently drawn attention after a period in which returns have moved differently across time frames. Over the past month, the stock is down about 11%, and down roughly 5% over the past 3 months, while the year to date return is a gain of about 3%. Looking back one year, the total return has fallen about 21%, compared with...

Patria Investments Limited ( NASDAQ:PAX ) stock is about to trade ex-dividend in three days. The ex-dividend date is...

Gold Royalty (GROY) has attracted attention after reporting first quarter 2026 earnings with sales of US$7.18 million and net income of US$1.77 million, a shift from a loss in the prior year period. See our latest analysis for Gold Royalty. The share price sits at US$3.73, with a 7 day share price return of 5.97% and a 90 day share price return that is down 11.19%. The 1 year total shareholder return of 152.03% indicates strong longer term momentum despite recent volatility and follows...

In early May 2026, Syndax Pharmaceuticals reported first-quarter 2026 revenue of US$64.86 million and a net loss of US$42.67 million, while also highlighting 12 Revuforj (revumenib) abstracts accepted for presentation at the June 2026 European Hematology Association Congress that showcase activity across multiple acute leukemia settings and genetic subtypes. An important angle for investors is the breadth of real-world and combination data for Revuforj, including post-transplant maintenance...

Recent performance snapshot Danaos (NYSE:DAC) has attracted fresh attention after recent share price moves, with the stock showing gains over the past month and past 3 months that stand out against its longer term performance profile. With a market value of about US$2.4b and reported revenue of US$1,042.847m alongside net income of US$519.888m, the company’s current pricing invites closer inspection of how investors are weighing its earnings power and risks. See our latest analysis for...

BioCryst Pharmaceuticals (NasdaqGS:BCRX) has granted Neopharmed Gentili exclusive European licensing rights to navenibart for hereditary angioedema. The agreement includes an upfront payment and potential future milestone payments to BioCryst. Neopharmed Gentili is expected to use its existing European commercial infrastructure to support the rollout of navenibart. At ISPOR 2026, BioCryst presented real world evidence on pediatric hereditary angioedema highlighting ongoing medical and...

Bruker Corporation recently reported first-quarter 2026 results, with sales rising to US$823.4 million from US$801.4 million a year earlier, while net income eased to US$14.4 million, and it reconfirmed full-year 2026 revenue guidance of US$3.57 billion to US$3.60 billion. The combination of higher quarterly sales but lower earnings, alongside unchanged full-year revenue expectations, highlights how Bruker is balancing growth investments and cost pressures as it enters the rest of 2026. We...

Recent performance snapshot for Gaming and Leisure Properties (GLPI) Gaming and Leisure Properties (GLPI) has moved quietly on recent trading data, with the stock down 1.5% on the day and 2.2% over the past week, while longer term returns remain positive. See our latest analysis for Gaming and Leisure Properties. At a share price of US$46.97, short term weakness, including a 1-day share price return that declined 1.53% and a 7-day share price return that declined 2.23%, contrasts with a...